MRC awards two medical research units at University of Cambridge £30m in funding
The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029
Read More
Tag: metabolic disorders
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
